The antiviral, Daclatasvir, downregulates Tribbles 2 pseudokinase and reverses enzalutamide resistance in prostate cancer

被引：0
|
作者：
Monga, Jitender
Guddeti, Rohith
Rogers, Craig
Gadgeel, Shirish
Chitale, Dhananjay
Ghosh, Jagadananda
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4751
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4751
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT
    Liu, Qiuli
    Tong, Dali
    Liu, Gaolei
    Xu, Jing
    Do, Khang
    Geary, Kyla
    Zhang, Dianzheng
    Zhang, Jun
    Zhang, Yao
    Li, Yaoming
    Bi, Gang
    Lan, Weihua
    Jiang, Jun
    CELL DEATH & DISEASE, 2017, 8 : e3007 - e3007
  • [32] Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
    Lin, Hui-Ming
    Mak, Blossom
    Yeung, Nicole
    Huynh, Kevin
    Meikle, Thomas G.
    Mellett, Natalie A.
    Kwan, Edmond M.
    Fettke, Heidi
    Tran, Ben
    Davis, Ian D.
    Mahon, Kate L.
    Zhang, Alison
    Stockler, Martin R.
    Briscoe, Karen
    Marx, Gavin
    Crumbaker, Megan
    Stricker, Phillip D.
    Du, Pan
    Yu, Jianjun
    Jia, Shidong
    Scheinberg, Tahlia
    Fitzpatrick, Michael
    Bonnitcha, Paul
    Sullivan, David R.
    Joshua, Anthony M.
    Azad, Arun A.
    Butler, Lisa M.
    Meikle, Peter J.
    Horvath, Lisa G.
    EBIOMEDICINE, 2021, 72
  • [33] Metabolic reprogramming fuels prostate cancer cells towards enzalutamide resistance
    Verma, Shiv S.
    Shankar, Eswar
    Kanwal, Rajnee
    Chan, Ricky
    Gupta, Sanjay
    CANCER RESEARCH, 2020, 80 (16)
  • [34] Targeting MCT inhibition to overcome enzalutamide resistance in prostate cancer.
    Bhattacharjee, Sayani
    Doan, Jonathan P.
    Wynn, Rebecca
    Nadiminty, Nagalakshmi
    CANCER RESEARCH, 2022, 82 (12)
  • [35] AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Wang, Hao
    Luber, Brandon
    Nakazawa, Mary
    Roeser, Jeffrey C.
    Chen, Yan
    Mohammad, Tabrez A.
    Chen, Yidong
    Fedor, Helen L.
    Lotan, Tamara L.
    Zheng, Qizhi
    De Marzo, Angelo M.
    Isaacs, John T.
    Isaacs, William B.
    Nadal, Rosa
    Paller, Channing J.
    Denmeade, Samuel R.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Luo, Jun
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11): : 1028 - 1038
  • [36] Tribbles pseudokinase 3 contributes cancer stemness in head and neck cancer cells by supporting SOX2 and EGFR expression
    Chang, Wen-Wei
    Huang, Yen-Ming
    Huang, Yu-Hao
    ANNALS OF ONCOLOGY, 2023, 34 : S1461 - S1461
  • [37] INCREASED GLYCOLYSIS AS A POTENTIAL MECHANISM FOR ENZALUTAMIDE-RESISTANCE IN PROSTATE CANCER
    Bhattacharjee, Sayani
    Doan, Jonathan
    Wynn, Rebecca
    Nadiminty, Nagalakshmi
    JOURNAL OF UROLOGY, 2021, 206 : E613 - E613
  • [38] Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancer
    Simpson, Kendall
    Allison, Derek B.
    He, Daheng
    Liu, Jinpeng
    Wang, Chi
    Liu, Xiaoqi
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2025, 392 (01):
  • [39] Enzalutamide-induced hypoxia attenuates response and promotes resistance to enzalutamide in preclinical models of prostate cancer.
    Maxwell, Pamela J.
    McKechnie, Melanie
    Duddy, Oisin
    Armstrong, Christopher W.
    Manley, Judith M.
    Ong, Chee Wee
    Worthington, Jenny
    Deryugina, Elena
    Quigley, James P.
    Zoubeidi, Amina
    Waugh, David J. J.
    LaBonte, Melissa J.
    CANCER RESEARCH, 2018, 78 (16) : 72 - 73
  • [40] Reduction of TGFBR2 in osteoblasts by enzalutamide causes drug resistance in prostate cancer bone metastasis
    Ark, Alexandra Vander
    Woodford, Erica
    Meng, Xiangqi
    Ganguly, Sourik
    Zhang, Xiaotun
    Madaj, Zachary
    Li, Xiaohong
    CANCER RESEARCH, 2018, 78 (13)
12345